Pharmaceuticals Global Industry Almanac 2019-2028

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value , and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.

All market data and forecasts are adjusted for inflation and all currency conversions used in the creation of this report have been calculated using yearly annual average exchange rates.

The global pharmaceuticals market registered revenue of $1,380 billion in 2023, representing a compound annual growth rate (CAGR) of 3.1% between 2018 and 2023.

North America dominated the global pharmaceuticals market in 2023, accounting for the largest share of 39.6%.

Scope

Save time carrying out entry-level research by identifying the size, growth, and leading players in the global pharmaceuticals market
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market
Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts

Reasons to Buy

What was the size of the global pharmaceuticals market by value in 2023?
What will be the size of the global pharmaceuticals market in 2028?
What factors are affecting the strength of competition in the global pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitors in the global pharmaceuticals market?

Product Code: MLIG240084-01

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Competitive landscape

2 Introduction

2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions

3 Global Pharmaceuticals

3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis

4 Macroeconomic Indicators

4.1. Country data

5 Pharmaceuticals in Asia-Pacific

5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis

6 Pharmaceuticals in Europe

6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis

7 Macroeconomic Indicators

7.1. Country data

8 Pharmaceuticals in France

8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis

9 Macroeconomic Indicators

9.1. Country data

10 Pharmaceuticals in Germany

10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis

11 Macroeconomic Indicators

11.1. Country data

12 Pharmaceuticals in Australia

12.1. Market Overview
12.2. Market Data
12.3. Market Segmentation
12.4. Market outlook
12.5. Five forces analysis

13 Macroeconomic Indicators

13.1. Country data

14 Pharmaceuticals in Brazil

14.1. Market Overview
14.2. Market Data
14.3. Market Segmentation
14.4. Market outlook
14.5. Five forces analysis

15 Macroeconomic Indicators

15.1. Country data

16 Pharmaceuticals in Canada

16.1. Market Overview
16.2. Market Data
16.3. Market Segmentation
16.4. Market outlook
16.5. Five forces analysis

17 Macroeconomic Indicators

17.1. Country data

18 Pharmaceuticals in China

18.1. Market Overview
18.2. Market Data
18.3. Market Segmentation
18.4. Market outlook
18.5. Five forces analysis

19 Macroeconomic Indicators

19.1. Country data

20 Pharmaceuticals in India

20.1. Market Overview
20.2. Market Data
20.3. Market Segmentation
20.4. Market outlook
20.5. Five forces analysis

21 Macroeconomic Indicators

21.1. Country data

22 Pharmaceuticals in Indonesia

22.1. Market Overview
22.2. Market Data
22.3. Market Segmentation
22.4. Market outlook
22.5. Five forces analysis

23 Macroeconomic Indicators

23.1. Country data

24 Pharmaceuticals in Italy

24.1. Market Overview
24.2. Market Data
24.3. Market Segmentation
24.4. Market outlook
24.5. Five forces analysis

25 Macroeconomic Indicators

25.1. Country data

26 Pharmaceuticals in Japan

26.1. Market Overview
26.2. Market Data
26.3. Market Segmentation
26.4. Market outlook
26.5. Five forces analysis

27 Macroeconomic Indicators

27.1. Country data

28 Pharmaceuticals in Mexico

28.1. Market Overview
28.2. Market Data
28.3. Market Segmentation
28.4. Market outlook
28.5. Five forces analysis

29 Macroeconomic Indicators

29.1. Country data

30 Pharmaceuticals in The Netherlands

30.1. Market Overview
30.2. Market Data
30.3. Market Segmentation
30.4. Market outlook
30.5. Five forces analysis

31 Macroeconomic Indicators

31.1. Country data

32 Pharmaceuticals in North America

32.1. Market Overview
32.2. Market Data
32.3. Market Segmentation
32.4. Market outlook
32.5. Five forces analysis

33 Pharmaceuticals in Russia

33.1. Market Overview
33.2. Market Data
33.3. Market Segmentation
33.4. Market outlook
33.5. Five forces analysis

34 Macroeconomic Indicators

34.1. Country data

35 Pharmaceuticals in Scandinavia

35.1. Market Overview
35.2. Market Data
35.3. Market Segmentation
35.4. Market outlook
35.5. Five forces analysis

36 Pharmaceuticals in Singapore

36.1. Market Overview
36.2. Market Data
36.3. Market Segmentation
36.4. Market outlook
36.5. Five forces analysis

37 Macroeconomic Indicators

37.1. Country data

38 Pharmaceuticals in South Africa

38.1. Market Overview
38.2. Market Data
38.3. Market Segmentation
38.4. Market outlook
38.5. Five forces analysis

39 Macroeconomic Indicators

39.1. Country data

40 Pharmaceuticals in South Korea

40.1. Market Overview
40.2. Market Data
40.3. Market Segmentation
40.4. Market outlook
40.5. Five forces analysis

41 Macroeconomic Indicators

41.1. Country data

42 Pharmaceuticals in Spain

42.1. Market Overview
42.2. Market Data
42.3. Market Segmentation
42.4. Market outlook
42.5. Five forces analysis

43 Macroeconomic Indicators

43.1. Country data

44 Pharmaceuticals in Turkey

44.1. Market Overview
44.2. Market Data
44.3. Market Segmentation
44.4. Market outlook
44.5. Five forces analysis

45 Macroeconomic Indicators

45.1. Country data

46 Pharmaceuticals in The United Kingdom

46.1. Market Overview
46.2. Market Data
46.3. Market Segmentation
46.4. Market outlook
46.5. Five forces analysis

47 Macroeconomic Indicators

47.1. Country data

48 Pharmaceuticals in The United States

48.1. Market Overview
48.2. Market Data
48.3. Market Segmentation
48.4. Market outlook
48.5. Five forces analysis

49 Macroeconomic Indicators

49.1. Country data

50 Company Profiles

50.1. BASF SE
50.2. Sinopharm Group Co Ltd
50.3. F. Hoffmann-La Roche Ltd
50.4. The Procter & Gamble Co
50.5. Shanghai Pharmaceuticals Holding Co Ltd
50.6. CSPC Pharmaceutical Group Ltd
50.7. Takeda Pharmaceutical Co Ltd
50.8. Novartis AG
50.9. GSK plc
50.10. AstraZeneca Plc
50.11. Sanofi
50.12. Roche Holding AG
50.13. Laboratoires Pierre Fabre SA
50.14. Ipsen SA
50.15. Les Laboratoires Servier SAS
50.16. Bayer AG
50.17. Boehringer Ingelheim GmbH
50.18. CSL Ltd
50.19. Astrazeneca Pty Ltd
50.20. Mayne Pharma Group Ltd
50.21. Hypera SA
50.22. Ache Laboratorios Farmaceuticos SA
50.23. EMS Sigma Pharma
50.24. Eurofarma Laboratorios SA
50.25. Johnson & Johnson
50.26. Sanofi-Aventis Canada Inc
50.27. Apotex Inc
50.28. Bausch Health Companies Inc
50.29. Jiangsu Hengrui Medicine Co Ltd
50.30. Lupin Ltd
50.31. Cipla Ltd
50.32. Dr. Reddy's Laboratories Ltd
50.33. PT Kalbe Farma Tbk
50.34. PT Kimia Farma Tbk
50.35. PT Tempo Scan Pacific Tbk
50.36. Pfizer Italia Srl
50.37. A. Menarini Industrie Farmaceutiche Riunite Srl
50.38. Chiesi Farmaceutici SpA
50.39. Recordati SpA
50.40. Daiichi Sankyo Co Ltd
50.41. Astellas Pharma Inc
50.42. Otsuka Holdings Co Ltd
50.43. Sanofi-Aventis de Mexico SA de CV
50.44. Genomma Lab Internacional SAB de CV
50.45. Bayer de Mexico SA de CV
50.46. Boehringer Ingelheim Mexico
50.47. Pfizer BV
50.48. Astellas Pharma Europe Ltd
50.49. Merck & Co Inc
50.50. AbbVie Inc
50.51. Pfizer Inc
50.52. Bristol-Myers Squibb Co
50.53. OTC Pharma International BV
50.54. Pharmstandard
50.55. Binnopharm Group
50.56. Novo Nordisk AS
50.57. H. Lundbeck AS
50.58. Pfizer Laboratories (Pty) Ltd
50.59. Aspen Pharmacare Holdings Ltd
50.60. Adcock Ingram Holdings Ltd
50.61. Chong Kun Dang Pharmaceutical Corp.
50.62. Yuhan Corp
50.63. Celltrion Inc
50.64. Hanmi Pharmaceuticals Co Ltd
50.65. Grifols SA
50.66. Almirall SA
50.67. Laboratorios Farmaceuticos Rovi SA
50.68. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
50.69. Deva Holding AS

51 Appendix

51.1. Methodology
51.2. About MarketLine

Product Code: MLIG240084-01

List of Tables

Table 1: Global pharmaceuticals market value: $ billion, 2018-23
Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2023
Table 3: Global pharmaceuticals market share: % share, by value, 2023
Table 4: Global pharmaceuticals market value forecast: $ billion, 2023-28
Table 5: Global Size of Population (million), 2019-23
Table 6: Global real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 7: Global GDP (Current Prices, $ Billion), 2019-23
Table 8: Global Inflation, 2019-23
Table 9: Global Consumer Price Index (Absolute), 2019-23
Table 10: Global exchange rate, 2018-23
Table 11: Asia-Pacific pharmaceuticals market value: $ billion, 2018-23
Table 12: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2023
Table 13: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2023-28
Table 14: Europe pharmaceuticals market value: $ billion, 2018-23
Table 15: Europe pharmaceuticals market geography segmentation: $ billion, 2023
Table 16: Europe pharmaceuticals market value forecast: $ billion, 2023-28
Table 17: Europe Size of Population (million), 2019-23
Table 18: Europe real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 19: Europe GDP (Current Prices, $ Billion), 2019-23
Table 20: Europe Inflation, 2019-23
Table 21: Europe Consumer Price Index (Absolute), 2019-23
Table 22: Europe exchange rate, 2018-23
Table 23: France pharmaceuticals market value: $ billion, 2018-23
Table 24: France pharmaceuticals market geography segmentation: $ billion, 2023
Table 25: France pharmaceuticals market value forecast: $ billion, 2023-28
Table 26: France Size of Population (million), 2019-23
Table 27: France real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 28: France GDP (Current Prices, $ Billion), 2019-23
Table 29: France Inflation, 2019-23
Table 30: France Consumer Price Index (Absolute), 2019-23
Table 31: France exchange rate, 2018-23
Table 32: Germany pharmaceuticals market value: $ billion, 2018-23
Table 33: Germany pharmaceuticals market geography segmentation: $ billion, 2023
Table 34: Germany pharmaceuticals market value forecast: $ billion, 2023-28
Table 35: Germany Size of Population (million), 2019-23
Table 36: Germany real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 37: Germany GDP (Current Prices, $ Billion), 2019-23
Table 38: Germany Inflation, 2019-23
Table 39: Germany Consumer Price Index (Absolute), 2019-23
Table 40: Germany exchange rate, 2018-23
Table 41: Australia pharmaceuticals market value: $ billion, 2018-23
Table 42: Australia pharmaceuticals market geography segmentation: $ billion, 2023
Table 43: Australia pharmaceuticals market value forecast: $ billion, 2023-28
Table 44: Australia Size of Population (million), 2019-23
Table 45: Australia real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 46: Australia GDP (Current Prices, $ Billion), 2019-23
Table 47: Australia Inflation, 2019-23
Table 48: Australia Consumer Price Index (Absolute), 2019-23
Table 49: Australia exchange rate, 2018-23
Table 50: Brazil pharmaceuticals market value: $ billion, 2018-23
Table 51: Brazil pharmaceuticals market geography segmentation: $ billion, 2023
Table 52: Brazil pharmaceuticals market value forecast: $ billion, 2023-28
Table 53: Brazil Size of Population (million), 2019-23
Table 54: Brazil real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 55: Brazil GDP (Current Prices, $ Billion), 2019-23
Table 56: Brazil Inflation, 2019-23
Table 57: Brazil Consumer Price Index (Absolute), 2019-23
Table 58: Brazil exchange rate, 2018-23
Table 59: Canada pharmaceuticals market value: $ billion, 2018-23
Table 60: Canada pharmaceuticals market geography segmentation: $ billion, 2023
Table 61: Canada pharmaceuticals market value forecast: $ billion, 2023-28
Table 62: Canada Size of Population (million), 2019-23
Table 63: Canada real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 64: Canada GDP (Current Prices, $ Billion), 2019-23
Table 65: Canada Inflation, 2019-23
Table 66: Canada Consumer Price Index (Absolute), 2019-23
Table 67: Canada exchange rate, 2018-23
Table 68: China pharmaceuticals market value: $ billion, 2018-23
Table 69: China pharmaceuticals market geography segmentation: $ billion, 2023
Table 70: China pharmaceuticals market value forecast: $ billion, 2023-28
Table 71: China Size of Population (million), 2019-23
Table 72: China real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 73: China GDP (Current Prices, $ Billion), 2019-23
Table 74: China Inflation, 2019-23
Table 75: China Consumer Price Index (Absolute), 2019-23
Table 76: China exchange rate, 2018-23
Table 77: India pharmaceuticals market value: $ billion, 2018-23
Table 78: India pharmaceuticals market geography segmentation: $ billion, 2023
Table 79: India pharmaceuticals market value forecast: $ billion, 2023-28
Table 80: India Size of Population (million), 2019-23
Table 81: India real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 82: India GDP (Current Prices, $ Billion), 2019-23
Table 83: India Inflation, 2019-23
Table 84: India Consumer Price Index (Absolute), 2019-23
Table 85: India exchange rate, 2018-23
Table 86: Indonesia pharmaceuticals market value: $ billion, 2018-23
Table 87: Indonesia pharmaceuticals market geography segmentation: $ billion, 2023
Table 88: Indonesia pharmaceuticals market value forecast: $ billion, 2023-28
Table 89: Indonesia Size of Population (million), 2019-23
Table 90: Indonesia real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 91: Indonesia GDP (Current Prices, $ Billion), 2019-23
Table 92: Indonesia Inflation, 2019-23
Table 93: Indonesia Consumer Price Index (Absolute), 2019-23

List of Figures

Figure 1: Global pharmaceuticals market value: $ billion, 2018-23
Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 3: Global pharmaceuticals market share: % share, by value, 2023
Figure 4: Global pharmaceuticals market value forecast: $ billion, 2023-28
Figure 5: Forces driving competition in the global pharmaceuticals market, 2023
Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2023
Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2023
Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2023
Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2023
Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2023
Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2018-23
Figure 12: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 13: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2023-28
Figure 14: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2023
Figure 15: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2023
Figure 16: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2023
Figure 17: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2023
Figure 18: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2023
Figure 19: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2023
Figure 20: Europe pharmaceuticals market value: $ billion, 2018-23
Figure 21: Europe pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 22: Europe pharmaceuticals market value forecast: $ billion, 2023-28
Figure 23: Forces driving competition in the pharmaceuticals market in Europe, 2023
Figure 24: Drivers of buyer power in the pharmaceuticals market in Europe, 2023
Figure 25: Drivers of supplier power in the pharmaceuticals market in Europe, 2023
Figure 26: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2023
Figure 27: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2023
Figure 28: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2023
Figure 29: France pharmaceuticals market value: $ billion, 2018-23
Figure 30: France pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 31: France pharmaceuticals market value forecast: $ billion, 2023-28
Figure 32: Forces driving competition in the pharmaceuticals market in France, 2023
Figure 33: Drivers of buyer power in the pharmaceuticals market in France, 2023
Figure 34: Drivers of supplier power in the pharmaceuticals market in France, 2023
Figure 35: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2023
Figure 36: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2023
Figure 37: Drivers of degree of rivalry in the pharmaceuticals market in France, 2023
Figure 38: Germany pharmaceuticals market value: $ billion, 2018-23
Figure 39: Germany pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 40: Germany pharmaceuticals market value forecast: $ billion, 2023-28
Figure 41: Forces driving competition in the pharmaceuticals market in Germany, 2023
Figure 42: Drivers of buyer power in the pharmaceuticals market in Germany, 2023
Figure 43: Drivers of supplier power in the pharmaceuticals market in Germany, 2023
Figure 44: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2023
Figure 45: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2023
Figure 46: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2023
Figure 47: Australia pharmaceuticals market value: $ billion, 2018-23
Figure 48: Australia pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 49: Australia pharmaceuticals market value forecast: $ billion, 2023-28
Figure 50: Forces driving competition in the pharmaceuticals market in Australia, 2023
Figure 51: Drivers of buyer power in the pharmaceuticals market in Australia, 2023
Figure 52: Drivers of supplier power in the pharmaceuticals market in Australia, 2023
Figure 53: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2023
Figure 54: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2023
Figure 55: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2023
Figure 56: Brazil pharmaceuticals market value: $ billion, 2018-23
Figure 57: Brazil pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 58: Brazil pharmaceuticals market value forecast: $ billion, 2023-28
Figure 59: Forces driving competition in the pharmaceuticals market in Brazil, 2023
Figure 60: Drivers of buyer power in the pharmaceuticals market in Brazil, 2023
Figure 61: Drivers of supplier power in the pharmaceuticals market in Brazil, 2023
Figure 62: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2023
Figure 63: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2023
Figure 64: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2023
Figure 65: Canada pharmaceuticals market value: $ billion, 2018-23
Figure 66: Canada pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 67: Canada pharmaceuticals market value forecast: $ billion, 2023-28
Figure 68: Forces driving competition in the pharmaceuticals market in Canada, 2023
Figure 69: Drivers of buyer power in the pharmaceuticals market in Canada, 2023
Figure 70: Drivers of supplier power in the pharmaceuticals market in Canada, 2023
Figure 71: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2023
Figure 72: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2023
Figure 73: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2023
Figure 74: China pharmaceuticals market value: $ billion, 2018-23
Figure 75: China pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 76: China pharmaceuticals market value forecast: $ billion, 2023-28
Figure 77: Forces driving competition in the pharmaceuticals market in China, 2023
Figure 78: Drivers of buyer power in the pharmaceuticals market in China, 2023
Figure 79: Drivers of supplier power in the pharmaceuticals market in China, 2023
Figure 80: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2023
Figure 81: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2023
Figure 82: Drivers of degree of rivalry in the pharmaceuticals market in China, 2023
Figure 83: India pharmaceuticals market value: $ billion, 2018-23
Figure 84: India pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 85: India pharmaceuticals market value forecast: $ billion, 2023-28
Figure 86: Forces driving competition in the pharmaceuticals market in India, 2023
Figure 87: Drivers of buyer power in the pharmaceuticals market in India, 2023
Figure 88: Drivers of supplier power in the pharmaceuticals market in India, 2023
Figure 89: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2023
Figure 90: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2023
Figure 91: Drivers of degree of rivalry in the pharmaceuticals market in India, 2023
Figure 92: Indonesia pharmaceuticals market value: $ billion, 2018-23
Figure 93: Indonesia pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 94: Indonesia pharmaceuticals market value forecast: $ billion, 2023-28

Pharmaceuticals Global Industry Almanac 2019-2028

Description

Table of Contents

List of Tables

Summary

Key Highlights

Scope

Reasons to Buy

Table of Contents

1 EXECUTIVE SUMMARY

2 Introduction

3 Global Pharmaceuticals

4 Macroeconomic Indicators

5 Pharmaceuticals in Asia-Pacific

6 Pharmaceuticals in Europe

7 Macroeconomic Indicators

8 Pharmaceuticals in France

9 Macroeconomic Indicators

10 Pharmaceuticals in Germany

11 Macroeconomic Indicators

12 Pharmaceuticals in Australia

13 Macroeconomic Indicators

14 Pharmaceuticals in Brazil

15 Macroeconomic Indicators

16 Pharmaceuticals in Canada

17 Macroeconomic Indicators

18 Pharmaceuticals in China

19 Macroeconomic Indicators

20 Pharmaceuticals in India

21 Macroeconomic Indicators

22 Pharmaceuticals in Indonesia

23 Macroeconomic Indicators

24 Pharmaceuticals in Italy

25 Macroeconomic Indicators

26 Pharmaceuticals in Japan

27 Macroeconomic Indicators

28 Pharmaceuticals in Mexico

29 Macroeconomic Indicators

30 Pharmaceuticals in The Netherlands

31 Macroeconomic Indicators

32 Pharmaceuticals in North America

33 Pharmaceuticals in Russia

34 Macroeconomic Indicators

35 Pharmaceuticals in Scandinavia

36 Pharmaceuticals in Singapore

37 Macroeconomic Indicators

38 Pharmaceuticals in South Africa

39 Macroeconomic Indicators

40 Pharmaceuticals in South Korea

41 Macroeconomic Indicators

42 Pharmaceuticals in Spain

43 Macroeconomic Indicators

44 Pharmaceuticals in Turkey

45 Macroeconomic Indicators

46 Pharmaceuticals in The United Kingdom

47 Macroeconomic Indicators

48 Pharmaceuticals in The United States

49 Macroeconomic Indicators

50 Company Profiles

51 Appendix

List of Tables

List of Figures